Biogennix Utilizes ImageIQ For Preclinical Image Analysis For FDA 510(k) Marketing Approval

CLEVELAND--(BUSINESS WIRE)--ImageIQ, an innovative Imaging Software and Contract Research Organization focused on supporting preclinical research and clinical trials, announced today that it has successfully supported Biogennix in completing its recent long-bone fracture healing and spine fusion preclinical studies. Both of these studies generated data that resulted in 510(k) marketing approvals by the US Food and Drug Administration (FDA).